Cheryl A. Hillery
Distinguished in Sickle Cell Disease

Dr. Cheryl A. Hillery

Pediatric Hematology Oncology
UPMC
Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
On Staff At
Accepting New Patients

Distinguished in Sickle Cell Disease
UPMC
Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease.

Dr. Hillery is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Her clinical research consists of co-authoring 33 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 26 articles and participated in 1 clinical trial in the study of Sickle Cell Disease.

Graduate Institution
Washington University In St Louis School Of Medicine
Residency
University of North Carolina Hospitals
Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in WI
Board Certifications
American Board Of Internal Medicine
American Board Of Pediatrics
Fellowships
University of North Carolina Hospitals
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 9 Less Insurance Carriers -

Locations

Pediatric Hematology Oncology in Lawrenceville
4401 Penn Avenue, Pittsburgh, PA 15224
Call: 412-692-5055

Additional Areas of Focus

Dr. Hillery has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease
A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Treatment Effect of GBT440 in Pediatric Participants With Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: August 15, 2025
Intervention Type: Drug
Study Drug: Voxelotor
Study Phase: Phase 2

33 Total Publications

Corrigendum to 'Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease' [Free Radic. Biol. Med. 215 (2024) 112-126].
Corrigendum to 'Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease' [Free Radic. Biol. Med. 215 (2024) 112-126].
Journal: Free radical biology & medicine
Published: March 27, 2025
View All 33 Publications
Similar Doctors
Advanced in Sickle Cell Disease
Dr. Steven Fein
Pediatric Hematology Oncology
Advanced in Sickle Cell Disease
Dr. Steven Fein
Pediatric Hematology Oncology

University Of Pittsburgh Physicians

200 Lothrop St, Muh 4 East, 
Pittsburgh, PA 
 (1.7 miles away)
412-383-1370
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Fein is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Fein is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Alpha Thalassemia, Blood Clots, Anemia, Bone Marrow Aspiration, and Splenectomy.

Experienced in Sickle Cell Disease
Dr. Michelle C. Perry
Pediatric Hematology Oncology
Experienced in Sickle Cell Disease
Dr. Michelle C. Perry
Pediatric Hematology Oncology
4401 Penn Ave, 
Pittsburgh, PA 
 (0.4 miles away)
412-692-5285
Languages Spoken:
English
See accepted insurances

Michelle Perry is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Perry is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hodgkin Lymphoma, and Immune Thrombocytopenic Purpura (ITP).

Experienced in Sickle Cell Disease
Dr. Lubna S. Mehyar
Pediatric Hematology Oncology
Experienced in Sickle Cell Disease
Dr. Lubna S. Mehyar
Pediatric Hematology Oncology
1 Medical Center Dr, 
Morgantown, WV 
 (56.0 miles away)
304-598-4000
Languages Spoken:
English
See accepted insurances

Lubna Mehyar is a Pediatric Hematologist Oncology provider in Morgantown, West Virginia. Dr. Mehyar is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Von Gierke Disease, Febrile Neutropenia, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

VIEW MORE SICKLE CELL DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hillery's expertise for a condition
ConditionClose
    • Distinguished
    • Anemia
      Dr. Hillery is
      Distinguished
      . Learn about Anemia.
      See more Anemia experts
    • Congenital Hemolytic Anemia
      Dr. Hillery is
      Distinguished
      . Learn about Congenital Hemolytic Anemia.
      See more Congenital Hemolytic Anemia experts
    • Hemoglobinopathy
      Dr. Hillery is
      Distinguished
      . Learn about Hemoglobinopathy.
      See more Hemoglobinopathy experts
    • Hemolytic Anemia
      Dr. Hillery is
      Distinguished
      . Learn about Hemolytic Anemia.
      See more Hemolytic Anemia experts
    • Sickle Cell Disease
      Dr. Hillery is
      Distinguished
      . Learn about Sickle Cell Disease.
      See more Sickle Cell Disease experts
    • Advanced
    • Hemolysis
      Dr. Hillery is
      Advanced
      . Learn about Hemolysis.
      See more Hemolysis experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.